Skip to content
2000
image of Application of Traditional Chinese Medicines in Diabetes Mellitus: From Pathogenesis to Clinical Practice

Abstract

Diabetes mellitus (DM) is a group of metabolic disorders characterised by insufficient insulin secretion and reduced insulin sensitivity in target tissues, leading to a range of metabolic abnormalities. DM has a profound global impact and exerts detrimental effects on patients’ health. Traditional Chinese Medicines (TCMs), characterised by dialectical treatment principles and a holistic therapeutic philosophy, have been shown to play an important role in the management and alleviation of DM.

In this review, we provide a concise overview of recent applications of TCMs in DM, summarise the underlying mechanisms, and discuss both the limitations of current practices and future prospects in this field. Numerous non-clinical and clinical studies have demonstrated the significant therapeutic advantages of TCMs in improving and alleviating DM. However, limitations persist, including variability among TCM formulations, the scarcity of high-quality randomised clinical trials, potential adverse effects and drug interactions, and challenges in standardisation.

Establishing rigorous and scientifically sound quality standards, conducting larger-scale multicentre randomised controlled trials, and further elucidating the underlying mechanisms may offer effective solutions to these challenges and support the broader application of TCMs in DM management.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010445359251204044548
2026-02-06
2026-02-21

  • From This Site

    /content/journals/cpb/10.2174/0113892010445359251204044548
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Wang K. Zhao H. Zhao X. Zhang X. Zhang W. Cheng Y. Ge J. Photobiomodulation for diabetes and its complications: A review of general presentation, mechanisms and efficacy. Ann. Med. 2024 56 1 2433684 10.1080/07853890.2024.2433684 39607829
    [Google Scholar]
  2. Fralick M. Jenkins A.J. Khunti K. Mbanya J.C. Mohan V. Schmidt M.I. Global accessibility of therapeutics for diabetes mellitus. Nat. Rev. Endocrinol. 2022 18 4 199 204 10.1038/s41574‑021‑00621‑y 35039662
    [Google Scholar]
  3. Esposito D. Boguszewski C.L. Colao A. Fleseriu M. Gatto F. Jørgensen J.O.L. Ragnarsson O. Ferone D. Johannsson G. Diabetes mellitus in patients with acromegaly: Pathophysiology, clinical challenges and management. Nat. Rev. Endocrinol. 2024 20 9 541 552 10.1038/s41574‑024‑00993‑x 38844688
    [Google Scholar]
  4. Schütt K. Forst T. Birkenfeld A.L. Zirlik A. Müller-Wieland D. Marx N. Diabetes mellitus and the heart. Exp. Clin. Endocrinol. Diabetes 2022 130 S 01 S123 S126 10.1055/a‑1624‑3593 35359012
    [Google Scholar]
  5. Xenoulis P.G. Fracassi F. Feline Comorbidities: Clinical perspective on diabetes mellitus and pancreatitis. J. Feline Med. Surg. 2022 24 7 651 661 10.1177/1098612X221106355 35775305
    [Google Scholar]
  6. Gal A. Burchell R.K. Diabetes mellitus and the kidneys. Vet. Clin. North Am. Small Anim. Pract. 2023 53 3 565 580 10.1016/j.cvsm.2023.01.006 36854633
    [Google Scholar]
  7. Jia G. Sowers J.R. Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension 2021 78 5 1197 1205 10.1161/HYPERTENSIONAHA.121.17981 34601960
    [Google Scholar]
  8. Kaze A.D. Santhanam P. Musani S.K. Ahima R. Echouffo-Tcheugui J.B. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: Findings from the look AHEAD study. J. Am. Heart Assoc. 2021 10 7 e016947 10.1161/JAHA.120.016947 33728932
    [Google Scholar]
  9. Piché M.E. Tchernof A. Després J.P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ. Res. 2020 126 11 1477 1500 10.1161/CIRCRESAHA.120.316101 32437302
    [Google Scholar]
  10. Cole J.B. Florez J.C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 2020 16 7 377 390 10.1038/s41581‑020‑0278‑5 32398868
    [Google Scholar]
  11. Tu W.J. Xue Y. Nie D. The prevalence and treatment of diabetes in China from 2013 to 2018. JAMA 2022 327 17 1706 10.1001/jama.2022.3014 35503354
    [Google Scholar]
  12. Ma R.C.W. Epidemiology of diabetes and diabetic complications in China. Diabetologia 2018 61 6 1249 1260 10.1007/s00125‑018‑4557‑7 29392352
    [Google Scholar]
  13. Zheng S. Xue T. Wang B. Guo H. Liu Q. Chinese medicine in the treatment of ulcerative colitis: The mechanisms of signaling pathway regulations. Am. J. Chin. Med. 2022 50 7 1781 1798 10.1142/S0192415X22500756 35950375
    [Google Scholar]
  14. Jian Y. Yuan H. Li D. Guo Q. Li X. Zhang S. Ning C. Zhang L. Jian F. Evaluation of the in vitro acaricidal activity of Chinese herbal compounds on the poultry red mite (Dermanyssus gallinae). Front. Vet. Sci. 2022 9 996422 10.3389/fvets.2022.996422 36238438
    [Google Scholar]
  15. Cheng Y. Li P. Yang Y. Zhang J. Yan F. Wang H. Microsatellites for Phytolacca acinose (Phytolaccaceae), a traditional medicinal herb Appl. Plant. Sci. 2017 5 10 apps.1700028 10.3732/apps.1700028
    [Google Scholar]
  16. Li D. Lu S. Jian Y. Cheng S. Zhao Q. Yuan H. Wang N. Liu Y. Zhang S. Zhang L. Wang R. Jian F. Acaricidal and repellent activities of ethanol extracts of nine chinese medicinal herbs against Rhipicephalus microplus (Acari: Ixodidae). Exp. Appl. Acarol. 2023 91 1 69 87 10.1007/s10493‑023‑00813‑3 37522955
    [Google Scholar]
  17. Zhang Y. Fang X.M. The pan-liver network theory: From traditional chinese medicine to western medicine. Chin. J. Physiol. 2023 66 6 401 436 10.4103/cjop.CJOP‑D‑22‑00131 38149555
    [Google Scholar]
  18. Liu S. Zhu J.J. Li J.C. The interpretation of human body in traditional Chinese medicine and its influence on the characteristics of TCM theory. Anat. Rec. (Hoboken) 2021 304 11 2559 2565 10.1002/ar.24643 34117702
    [Google Scholar]
  19. Yang J. Li Z. Li M. Lie B. Duan T. Chen D. Xia T. Xie H. Lin G. The protective effect of bajijiasu on the treatment of hypertensive nephropathy in rats. Curr. Mol. Pharmacol. 2023 16 7 e051022209617 10.2174/1874467215666221005141210 36200156
    [Google Scholar]
  20. Duan T. Li M. Lie B. Lin Z. Li M. Xia T. Lin G. Meng L. Lu X. Li Z. Yang J. The protective effect of the Asystasia chelonoides extracts on hypertensive nephropathy rats. Curr. Pharm. Biotechnol. 2023 24 13 1708 1714 10.2174/1389201024666230320120925 36959153
    [Google Scholar]
  21. Duan T. Li M. Lin Z. Meng L. Li M. Xia T. Zhang X. Lin G. Yan L. Liang M. Zhu Q. Li Z. Yang J. The protective effect of vitexin on hypertensive nephropathy rats. Kidney Blood Press. Res. 2024 49 1 753 762 10.1159/000540618 39079512
    [Google Scholar]
  22. Zhang B. Zhou L. Chen K. Fang X. Li Q. Gao Z. Lian F. Li M. Tian J. Zhao L. Tong X. Investigation on phenomics of traditional Chinese Medicine from the diabetes. Phenomics 2024 4 3 257 268 10.1007/s43657‑023‑00146‑6 39398423
    [Google Scholar]
  23. Lin Z. Zhang J. Duan T. Yang J. Yang Y. Trefoil factor 3 can stimulate Th17 cell response in the development of type 2 diabetes mellitus. Sci. Rep. 2024 14 1 10340 10.1038/s41598‑024‑60426‑7 38710764
    [Google Scholar]
  24. Antar S.A. Ashour N.A. Sharaky M. Khattab M. Ashour N.A. Zaid R.T. Roh E.J. Elkamhawy A. Al-Karmalawy A.A. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed. Pharmacother. 2023 168 115734 10.1016/j.biopha.2023.115734 37857245
    [Google Scholar]
  25. Yu M.G. Gordin D. Fu J. Park K. Li Q. King G.L. Protective factors and the pathogenesis of complications in diabetes. Endocr. Rev. 2024 45 2 227 252 10.1210/endrev/bnad030 37638875
    [Google Scholar]
  26. Colagiuri S. Definition and classification of diabetes and prediabetes and emerging data on phenotypes. Endocrinol. Metab. Clin. North Am. 2021 50 3 319 336 10.1016/j.ecl.2021.06.004 34399948
    [Google Scholar]
  27. ElSayed N.A. Aleppo G. Aroda V.R. Bannuru R.R. Brown F.M. Bruemmer D. Collins B.S. Gaglia J.L. Hilliard M.E. Isaacs D. Johnson E.L. Kahan S. Khunti K. Leon J. Lyons S.K. Perry M.L. Prahalad P. Pratley R.E. Seley J.J. Stanton R.C. Gabbay R.A. Classification and diagnosis of diabetes: Standards of Care in Diabetes—2023 Diabetes Care 2023 46 S19 S40 Suppl. 1 10.2337/dc23‑S002 36507649
    [Google Scholar]
  28. Redondo M.J. Gignoux C.R. Dabelea D. Hagopian W.A. Onengut-Gumuscu S. Oram R.A. Rich S.S. Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol. 2022 10 8 597 608 10.1016/S2213‑8587(22)00159‑0 35724677
    [Google Scholar]
  29. Majety P. Lozada Orquera F.A. Edem D. Hamdy O. Pharmacological approaches to the prevention of type 2 diabetes mellitus. Front. Endocrinol. 2023 14 1118848 10.3389/fendo.2023.1118848 36967777
    [Google Scholar]
  30. Ye W. Luo C. Huang J. Li C. Liu Z. Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis. BMJ 2022 377 e067946 10.1136/bmj‑2021‑067946 35613728
    [Google Scholar]
  31. Tobias D.K. Merino J. Ahmad A. Aiken C. Benham J.L. Bodhini D. Clark A.L. Colclough K. Corcoy R. Cromer S.J. Duan D. Felton J.L. Francis E.C. Gillard P. Gingras V. Gaillard R. Haider E. Hughes A. Ikle J.M. Jacobsen L.M. Kahkoska A.R. Kettunen J.L.T. Kreienkamp R.J. Lim L.L. Männistö J.M.E. Massey R. Mclennan N.M. Miller R.G. Morieri M.L. Most J. Naylor R.N. Ozkan B. Patel K.A. Pilla S.J. Prystupa K. Raghavan S. Rooney M.R. Schön M. Semnani-Azad Z. Sevilla-Gonzalez M. Svalastoga P. Takele W.W. Tam C.H. Thuesen A.C.B. Tosur M. Wallace A.S. Wang C.C. Wong J.J. Yamamoto J.M. Young K. Amouyal C. Andersen M.K. Bonham M.P. Chen M. Cheng F. Chikowore T. Chivers S.C. Clemmensen C. Dabelea D. Dawed A.Y. Deutsch A.J. Dickens L.T. DiMeglio L.A. Dudenhöffer-Pfeifer M. Evans-Molina C. Fernández-Balsells M.M. Fitipaldi H. Fitzpatrick S.L. Gitelman S.E. Goodarzi M.O. Grieger J.A. Guasch-Ferré M. Habibi N. Hansen T. Huang C. Harris-Kawano A. Ismail H.M. Hoag B. Johnson R.K. Jones A.G. Koivula R.W. Leong A. Leung G.K.W. Libman I.M. Liu K. Long S.A. Lowe W.L. Morton R.W. Motala A.A. Onengut-Gumuscu S. Pankow J.S. Pathirana M. Pazmino S. Perez D. Petrie J.R. Powe C.E. Quinteros A. Jain R. Ray D. Ried-Larsen M. Saeed Z. Santhakumar V. Kanbour S. Sarkar S. Monaco G.S.F. Scholtens D.M. Selvin E. Sheu W.H.H. Speake C. Stanislawski M.A. Steenackers N. Steck A.K. Stefan N. Støy J. Taylor R. Tye S.C. Ukke G.G. Urazbayeva M. Van der Schueren B. Vatier C. Wentworth J.M. Hannah W. White S.L. Yu G. Zhang Y. Zhou S.J. Beltrand J. Polak M. Aukrust I. de Franco E. Flanagan S.E. Maloney K.A. McGovern A. Molnes J. Nakabuye M. Njølstad P.R. Pomares-Millan H. Provenzano M. Saint-Martin C. Zhang C. Zhu Y. Auh S. de Souza R. Fawcett A.J. Gruber C. Mekonnen E.G. Mixter E. Sherifali D. Eckel R.H. Nolan J.J. Philipson L.H. Brown R.J. Billings L.K. Boyle K. Costacou T. Dennis J.M. Florez J.C. Gloyn A.L. Gomez M.F. Gottlieb P.A. Greeley S.A.W. Griffin K. Hattersley A.T. Hirsch I.B. Hivert M.F. Hood K.K. Josefson J.L. Kwak S.H. Laffel L.M. Lim S.S. Loos R.J.F. Ma R.C.W. Mathieu C. Mathioudakis N. Meigs J.B. Misra S. Mohan V. Murphy R. Oram R. Owen K.R. Ozanne S.E. Pearson E.R. Perng W. Pollin T.I. Pop-Busui R. Pratley R.E. Redman L.M. Redondo M.J. Reynolds R.M. Semple R.K. Sherr J.L. Sims E.K. Sweeting A. Tuomi T. Udler M.S. Vesco K.K. Vilsbøll T. Wagner R. Rich S.S. Franks P.W. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat. Med. 2023 29 10 2438 2457 10.1038/s41591‑023‑02502‑5 37794253
    [Google Scholar]
  32. Perry R.J. Wang Y. Cline G.W. Rabin-Court A. Song J.D. Dufour S. Zhang X.M. Petersen K.F. Shulman G.I. Leptin mediates a glucose-fatty acid cycle to maintain glucose homeostasis in starvation. Cell 2018 172 1-2 234 248.e17 10.1016/j.cell.2017.12.001 29307489
    [Google Scholar]
  33. Perry R.J. Camporez J.P.G. Kursawe R. Titchenell P.M. Zhang D. Perry C.J. Jurczak M.J. Abudukadier A. Han M.S. Zhang X.M. Ruan H.B. Yang X. Caprio S. Kaech S.M. Sul H.S. Birnbaum M.J. Davis R.J. Cline G.W. Petersen K.F. Shulman G.I. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015 160 4 745 758 10.1016/j.cell.2015.01.012 25662011
    [Google Scholar]
  34. Chen Y. Zeng W. Chen W. Zhang Y. Zhu T. Sun J. Liang Z. Wang L. Yang Z. Wu B. Song B. Wang F. Liang Y. Gong L. Zheng J. Gao F. Evaluating the correlation of the impairment between skeletal muscle and heart using MRI in a spontaneous type 2 diabetes mellitus rhesus monkey model. Acta Diabetol. 2020 57 6 673 679 10.1007/s00592‑019‑01460‑0 31938886
    [Google Scholar]
  35. Cheng L. Wang J. Dai H. Duan Y. An Y. Shi L. Lv Y. Li H. Wang C. Ma Q. Li Y. Li P. Du H. Zhao B. Brown and beige adipose tissue: A novel therapeutic strategy for obesity and type 2 diabetes mellitus. Adipocyte 2021 10 1 48 65 10.1080/21623945.2020.1870060 33403891
    [Google Scholar]
  36. Rizzo M.R. Di Meo I. Polito R. Auriemma M.C. Gambardella A. di Mauro G. Capuano A. Paolisso G. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment. Pharmacol. Res. 2022 176 106062 10.1016/j.phrs.2022.106062 35017046
    [Google Scholar]
  37. Longo S. Rizza S. Federici M. Microbiota-gut-brain axis: Relationships among the vagus nerve, gut microbiota, obesity, and diabetes. Acta Diabetol. 2023 60 8 1007 1017 10.1007/s00592‑023‑02088‑x 37058160
    [Google Scholar]
  38. Pan L. Li Z. Wang Y. Zhang B. Liu G. Liu J. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus. J. Ethnopharmacol. 2020 258 112842 10.1016/j.jep.2020.112842 32333952
    [Google Scholar]
  39. Wang L. Zhang D. Zhan W. Zeng Z. Yin J. Wang K. Wang H. Song L. Gu Z. Guo C. Zhong Q. Wang W. Rong X. Bei W. Guo J. Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs. Biomed. Pharmacother. 2022 156 113831 10.1016/j.biopha.2022.113831 36228370
    [Google Scholar]
  40. Tian J. Bai B. Gao Z. Yang Y. Wu H. Wang X. Wang J. Li M. Tong X. Alleviation effects of GQD, a Traditional Chinese Medicine Formula, on diabetes rats linked to modulation of the gut microbiome. Front. Cell. Infect. Microbiol. 2021 11 740236 10.3389/fcimb.2021.740236 34692563
    [Google Scholar]
  41. Sun R. Huang W. Xiao Y. Wang D. Mu G. Nan H. Ni B. Huang X. Wang H. Liu Y. Fu Q. Zhao J. Shenlian (SL) decoction, a Traditional Chinese Medicine compound, may ameliorate blood glucose via mediating the gut microbiota in db/db mice. J. Diabetes Res. 2022 2022 1 20 10.1155/2022/7802107 35187178
    [Google Scholar]
  42. Yan M. Liu S. Zeng W. Guo Q. Mei Y. Shao X. Su L. Liu Z. Zhang Y. Wang L. Diao H. Rong X. Guo J. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice. Biomed. Pharmacother. 2023 164 114919 10.1016/j.biopha.2023.114919 37302318
    [Google Scholar]
  43. Gao W. Tian M. Li M. Gao S. Wei X. Gao C. Zhou Y. Li T. Wang H. Bian B. Si N. Zhao W. Zhao H. Study on the potential mechanism of Qingxin Lianzi Yin Decoction on renoprotection in db/db mice via network pharmacology and metabolomics. Phytomedicine 2024 126 155222 10.1016/j.phymed.2023.155222 38382279
    [Google Scholar]
  44. Shen Q. Fang J. Guo H. Su X. Zhu B. Yao X. Wang Y. Cao A. Wang H. Wang L. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease. Free Radic. Biol. Med. 2023 203 45 57 10.1016/j.freeradbiomed.2023.03.022 37030337
    [Google Scholar]
  45. Cao M. Yang J. Ye H. Cui G. Li W. Zhang X. Leech granules inhibit ferroptosis and alleviate renal injury in mice with diabetic kidney disease. J. Ethnopharmacol. 2025 337 Pt 3 118995 10.1016/j.jep.2024.118995 39490713
    [Google Scholar]
  46. Tian Y. Jing G. Yin R. Ma M. Cao W. Zhang M. Neuroprotective effects of traditional Chinese medicine Naofucong on diabetic cognitive impairment: Mechanisms involving insulin-degrading enzyme-mediated degradation of Amyloid-β and inhibition of ERK/JNK/p38 MAPK signaling pathway. Brain Res. 2025 1849 149365 10.1016/j.brainres.2024.149365 39617284
    [Google Scholar]
  47. Liu J. Ren J. Zhou L. Tan K. Du D. Xu L. Cao W. Zhang Y. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease. J. Ethnopharmacol. 2024 334 118517 10.1016/j.jep.2024.118517 38972525
    [Google Scholar]
  48. Li X. Wang J. Yan J. He J.C. Li Y. Zhong Y. Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease. Biomed. Pharmacother. 2024 171 116107 10.1016/j.biopha.2023.116107 38215692
    [Google Scholar]
  49. Ji L. Han H. Shan X. Zhao P. Chen H. Zhang C. Xu M. Lu R. Guo W. Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2. Eur. J. Pharmacol. 2024 974 176609 10.1016/j.ejphar.2024.176609 38677536
    [Google Scholar]
  50. Wang D. Yan B. Wang A. Sun Q. Pang J. Cui Y. Tian G. Tu-Xian Decoction ameliorates diabetic cognitive impairment by inhibiting DAPK-1. Chin. J. Nat. Med. 2023 21 12 950 960 10.1016/S1875‑5364(23)60428‑5 38143108
    [Google Scholar]
  51. Feng H. Wu T. Chin J. Ding R. Long C. Wang G. Yan D. Ma X. Yue R. Tangzu granule alleviate neuroinflammation in diabetic peripheral neuropathy by suppressing pyroptosis through P2X7R/NLRP3 signaling pathway. J. Ethnopharmacol. 2025 337 Pt 1 118792 10.1016/j.jep.2024.118792 39251151
    [Google Scholar]
  52. Wang Y. Chen Y. Liang X. Zhu L. Wen X. Network pharmacology and transcriptomics explore the therapeutic effects of Ermiao Wan categorized formulas for diabetes in mice. Sci. Rep. 2024 14 1 27014 10.1038/s41598‑024‑78364‑9 39506066
    [Google Scholar]
  53. Wang S. Taledaohan A. Tuohan M. Zhang J. Li Y. Song W. Wang Y. Liang X. Wu Q. Jinmaitong alleviates diabetic neuropathic pain by inhibiting JAK2/STAT3 signaling in microglia of diabetic rats. J. Ethnopharmacol. 2024 333 118442 10.1016/j.jep.2024.118442 38852640
    [Google Scholar]
  54. Zhang J. Zhou R. Deng L. Cao G. Zhang Y. Xu H. Hou J. Ju S. Yang H. Huangbai liniment and berberine promoted wound healing in high-fat diet/Streptozotocin-induced diabetic rats. Biomed. Pharmacother. 2022 150 112948 10.1016/j.biopha.2022.112948 35430394
    [Google Scholar]
  55. Song W. Sun Y. Liang X. Zhang Q. Xie J. Wang C. Liu W. Jinmaitong ameliorates diabetes-induced peripheral neuropathy in rats through Wnt/β-catenin signaling pathway. J. Ethnopharmacol. 2021 266 113461 10.1016/j.jep.2020.113461 33039625
    [Google Scholar]
  56. Hu M. Li H. Ni S. Wang S. The protective effects of Zhi-Gan-Cao-Tang against diabetic myocardial infarction injury and identification of its effective constituents. J. Ethnopharmacol. 2023 309 116320 10.1016/j.jep.2023.116320 36828197
    [Google Scholar]
  57. Wang J.S. Li X. Chen Z.L. Feng J.L. Bao B.H. Deng S. Dai H.H. Meng F.C. Wang B. Li H.S. Effect of leech-centipede medicine on improving erectile function in DIED rats via PKC signalling pathway-related molecules. J. Ethnopharmacol. 2021 267 113463 10.1016/j.jep.2020.113463 33049347
    [Google Scholar]
  58. Liu S. Li K. Zhao Y. Wang W. Bao J. Wang X. Shi L. Zhou L. Fu Q. Fermented Gynochthodes officinalis (F.C.How) Razafim. & B.Bremer alleviates diabetic erectile dysfunction by attenuating oxidative stress and regulating PI3K/Akt/eNOS pathway. J. Ethnopharmacol. 2023 307 116249 10.1016/j.jep.2023.116249 36775080
    [Google Scholar]
  59. Wang Z. Du H. Peng W. Yang S. Feng Y. Ouyang H. Zhu W. Liu R. Efficacy and mechanism of Pueraria lobata and Pueraria thomsonii polysaccharides in the treatment of type 2 diabetes. Nutrients 2022 14 19 3926 10.3390/nu14193926 36235582
    [Google Scholar]
  60. Yang D. Tan Y. Zhang Y. Song J. Luo Y. Luo Y. Fei X. Ru Y. Li B. Jiang J. Kuai L. Sheng-ji Hua-yu ointment ameliorates cutaneous wound healing in diabetes via up-regulating CCN1. J. Ethnopharmacol. 2023 303 115954 10.1016/j.jep.2022.115954 36435409
    [Google Scholar]
  61. Cui X. Liu T. Bai Y. Zhang M. Li G. Zhang Y. Yuan Y. Zhang Y. Yu L. Han L. Wu Y. Shexiang tongxin dropping pill promotes angiogenesis through VEGF/eNOS signaling pathway on diabetic coronary microcirculation dysfunction. Chin. J. Integr. Med. 2024 30 10 886 895 10.1007/s11655‑024‑3658‑z 38753274
    [Google Scholar]
  62. Fu X. Zhou X. Liu Y. Lei Y. Xie H. Leng Y. Gao H. Xie C. Exploration of SQC formula effect on type 2 diabetes mellitus by whole transcriptome profile in rats. Endocr. Metab. Immune Disord. Drug Targets 2021 21 7 1261 1269 10.2174/1871530321666210225125141 33632114
    [Google Scholar]
  63. Li J. Guo X. Huang Y. Ren Y. Liang H. Xie X. Zhang M. Exploring the mechanism of Bushen Huoxue prescription in the treatment of early diabetic retinal edema from the perspective of inner blood-retinal barrier injury. J. Ethnopharmacol. 2024 323 117658 10.1016/j.jep.2023.117658 38160865
    [Google Scholar]
  64. Peng M. Xia T. Zhong Y. Zhao M. Yue Y. Liang L. Zhong R. Zhang H. Li C. Cao X. Yang M. Wang Y. Shu Z. Integrative pharmacology reveals the mechanisms of Erzhi Pill, a traditional Chinese formulation, against diabetic cardiomyopathy. J. Ethnopharmacol. 2022 296 115474 10.1016/j.jep.2022.115474 35716918
    [Google Scholar]
  65. Dai X. Liu Y. Liu T. Zhang Y. Wang S. Xu T. Yin J. Shi H. Ye Z. Zhu R. Gao J. Dong G. Zhao D. Gao S. Wang X. Prentki M. Brὂmme D. Wang L. Zhang D. SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice. J. Ethnopharmacol. 2024 319 Pt 2 117167 10.1016/j.jep.2023.117167 37716489
    [Google Scholar]
  66. He T. Sun P. Liu B. Wan S. Fang P. Chen J. Huang G. Min W. Puffball spores improve wound healing in a diabetic rat model. Front. Endocrinol. 2022 13 942549 10.3389/fendo.2022.942549 36120443
    [Google Scholar]
  67. Li H. Hao G. Tang S. Sun H. Fang Y. Pang X. Liu H. Ji Q. Wang X. Tian J. Jiang K. Song X. Zhu R. Han J. Wang W. HuoXue JieDu formula improves diabetic retinopathy in rats by regulating microRNAs. J. Ethnopharmacol. 2021 268 113616 10.1016/j.jep.2020.113616 33271246
    [Google Scholar]
  68. Yu B. Zhou M. Dong Z. Zheng H. Zhao Y. Zhou J. Zhang C. Wei F. Yu G. Liu W.J. Liu H. Wang Y. Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy. Pharm. Biol. 2023 61 1 1222 1233 10.1080/13880209.2023.2241521 37565668
    [Google Scholar]
  69. Yi Z. Yang B. Wan F. Lu J. Liu D. Lin L. Xu Y. Cen Z. Fan M. Liu W. Lu Q. Jiang G. Zhang Y. Song E. Gao J. Ye D. Chinese medicine Linggui Zhugan formula protects against diabetic kidney disease in close association with inhibition of proteinase 3-mediated podocyte apoptosis in mice. J. Ethnopharmacol. 2024 335 118650 10.1016/j.jep.2024.118650 39094755
    [Google Scholar]
  70. Tang Y. Gao Y. Nie K. Wang H. Chen S. Su H. Huang W. Dong H. Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP/PKA/CREB signaling pathway. J. Ethnopharmacol. 2024 324 117829 10.1016/j.jep.2024.117829 38296172
    [Google Scholar]
  71. Qiyan zheng; Zhang, X.; Guo, J.; Wang, Y.; Jiang, Y.; Li, S.; Liu, Y.N.; Liu, W.J. JinChan YiShen TongLuo Formula ameliorate mitochondrial dysfunction and apoptosis in diabetic nephropathy through the HIF-1α-PINK1-Parkin pathway. J. Ethnopharmacol. 2024 328 117863 10.1016/j.jep.2024.117863 38325670
    [Google Scholar]
  72. Fang T. Wang J. Sun S. Deng X. Xue M. Han F. Sun B. Chen L. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53. Phytomedicine 2024 130 155659 10.1016/j.phymed.2024.155659 38759318
    [Google Scholar]
  73. Si H. Chen Y. Hu D. Yao S. Yang J. Wen X. A graminan type fructan from Achyranthes bidentata prevents the kidney injury in diabetic mice by regulating gut microbiota. Carbohydr. Polym. 2024 339 122275 10.1016/j.carbpol.2024.122275 38823933
    [Google Scholar]
  74. Kuang L. You Y. Qi J. Chen J. Zhou X. Ji S. Cheng J. Kwan H.Y. Jiang P. Sun X. Su M. Wang M. Chen W. Luo R. Zhao X. Zhou L. Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK/AKT/mTOR signaling pathway. Environ. Toxicol. 2024 39 6 3481 3499 10.1002/tox.24179 38456329
    [Google Scholar]
  75. Chen Q. Hao H. Guo Z. Zuo Y. Cheng C.K. Zhang C.L. Wang L. Lu A. Huang Y. He L. Pien Tze Huang (PZH) protects endothelial function in diabetic mice. Life Sci. 2024 349 122723 10.1016/j.lfs.2024.122723 38754816
    [Google Scholar]
  76. Liang D. Liu L. Qi Y. Nan F. Huang J. Tang S. Tang J. Chen N. Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. J. Ethnopharmacol. 2024 324 117745 10.1016/j.jep.2024.117745 38228231
    [Google Scholar]
  77. Yue W. Sun N. Zhang J. Zhang W. Wu Y. Qu X. Zong J. Xu G. Alleviated diabetic osteoporosis and peripheral neuropathic pain by Rehmannia glutinosa Libosch polysaccharide via increasing regulatory T cells. Int. J. Biol. Macromol. 2024 277 Pt 4 134241 10.1016/j.ijbiomac.2024.134241 39084449
    [Google Scholar]
  78. Song Z. Yan A. Li Z. Shang Y. Chen R. Yang Z. Guo Z. Zhang Y. Wen T. Ogaji O.D. Wang Y. Integrated metabolomic and transcriptomic analysis reveals the effects and mechanisms of Jinqi Jiangtang tablets on type 2 diabetes. Phytomedicine 2024 134 155957 10.1016/j.phymed.2024.155957 39181101
    [Google Scholar]
  79. Zhang Q. Jin W. Wang H. Tang C. Zhao X. Wang Y. Sun L. Piao C. Inhibition of endoplasmic reticulum stress and excessive autophagy by Jiedu Tongluo Tiaogan Formula via a CaMKKβ/AMPK pathway contributes to protect pancreatic β-cells. J. Ethnopharmacol. 2024 333 118440 10.1016/j.jep.2024.118440 38885916
    [Google Scholar]
  80. Xie J. Lin H. Jin F. Luo Y. Yang P. Song J. Yao W. Lin W. Yuan D. Zuo A. Sun J. Wang M. Jia Wei Qingxin Lotus Seed Drink ameliorates epithelial mesenchymal transition injury in diabetic kidney disease via inhibition of JMJD1C/SP1/ZEB1 signaling pathway. Phytomedicine 2024 135 156142 10.1016/j.phymed.2024.156142 39541663
    [Google Scholar]
  81. Liu W. Xu S. Zhang B. Sun X. Ramulus Mori (Sangzhi) alkaloids alleviate diabetic nephropathy through improving gut microbiota disorder. Nutrients 2024 16 14 2346 10.3390/nu16142346 39064789
    [Google Scholar]
  82. Zhang X. Huo Z. Jia X. Xiong Y. Li B. Zhang L. Li X. Li X. Fang Y. Dong X. Chen G. (+)-Catechin ameliorates diabetic nephropathy injury by inhibiting endoplasmic reticulum stress-related NLRP3-mediated inflammation. Food Funct. 2024 15 10 5450 5465 10.1039/D3FO05400D 38687305
    [Google Scholar]
  83. Zheng Y. Wang C. Liu W. Chen J. Sun Y. Chang D. Wang H. Xu W. Lu J.J. Zhou X. Huang M. Upregulation of Nrf2 signaling: A key molecular mechanism of Baicalin’s neuroprotective action against diabetes-induced cognitive impairment. Biomed. Pharmacother. 2024 174 116579 10.1016/j.biopha.2024.116579 38631145
    [Google Scholar]
  84. Li P. Wang T. Guo H. Liu Y. Zhao H. Ren T. Tang Y. Wang Y. Zou M. Pramipexole improves depression-like behavior in diabetes mellitus with depression rats by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing impaired neuroplasticity. J. Affect. Disord. 2024 356 586 596 10.1016/j.jad.2024.04.073 38657764
    [Google Scholar]
  85. Lan J.P. Xue Y.F. Pu J.Y. Ding Y. Gan Z.Y. Yang Y.B. Wang Z.T. Jie X.L. Yang L. Plantaginis semen ameliorates diabetic kidney disease via targeting the sphingosine kinase 1/sphingosine-1-phosphate pathway. J. Ethnopharmacol. 2024 331 118221 10.1016/j.jep.2024.118221 38677576
    [Google Scholar]
  86. jia, J.; Tan, R.; Xu, L.; Wang, H.; Li, J.; Su, H.; Zhong, X.; Liu, P.; Wang, L. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis. Int. Immunopharmacol. 2024 135 112303 10.1016/j.intimp.2024.112303 38776855
    [Google Scholar]
  87. Zhang S. Zhang Y. Wen Z. Yang Y. Bu T. Wei R. Chen Y. Ni Q. Jinkui Shenqi pills ameliorate diabetes by regulating hypothalamic insulin resistance and POMC/AgRP expression and activity. Phytomedicine 2024 126 155297 10.1016/j.phymed.2023.155297 38342019
    [Google Scholar]
  88. Li Q. Wang Y. Yan J. Yuan R. Zhang J. Guo X. Zhao M. Li F. Li X. Osthole ameliorates early diabetic kidney damage by suppressing oxidative stress, inflammation and inhibiting TGF-β1/Smads signaling pathway. Int. Immunopharmacol. 2024 133 112131 10.1016/j.intimp.2024.112131 38669945
    [Google Scholar]
  89. Zhang Z.T. Liang Q.F. Wang X. Wang R.S. Duan T.T. Wang S.M. Tang D. Protective effects of Huang-Qi-Ge-Gen decoction against diabetic liver injury through regulating PI3K/AKT/Nrf2 pathway and metabolic profiling. J. Ethnopharmacol. 2024 323 117647 10.1016/j.jep.2023.117647 38163558
    [Google Scholar]
  90. Li Z. Zhao Z. Chen S. Wang X. Wang D. Nie X. Yao Y. Ge-Gen-Qin-Lian decoction alleviates the symptoms of type 2 diabetes mellitus with inflammatory bowel disease via regulating the AGE-RAGE pathway. BMC Complementary Medicine Therapies 2024 24 1 225 10.1186/s12906‑024‑04526‑x 38858747
    [Google Scholar]
  91. Long P. Guo C. Wen T. Luo T. Yang L. Li Y. Wen A. Wang W. Wen X. He M. Therapeutic effects of Mudan granules on diabetic retinopathy: Mitigating fibrogenesis caused by FBN2 deficiency and inflammation associated with TNF-α elevation. J. Ethnopharmacol. 2025 337 Pt 3 118963 10.1016/j.jep.2024.118963 39490708
    [Google Scholar]
  92. Xia T. He W. Luo Z. Wang K. Tan X. Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway. Int. J. Biol. Macromol. 2024 270 Pt 2 132256 10.1016/j.ijbiomac.2024.132256 38729481
    [Google Scholar]
  93. Bi T. Feng R. Ren W. Hang T. Zhao T. Zhan L. ZiBu PiYin recipe regulates central and peripheral Aβ metabolism and improves diabetes-associated cognitive decline in ZDF rats. J. Ethnopharmacol. 2025 337 Pt 1 118808 10.1016/j.jep.2024.118808 39299360
    [Google Scholar]
  94. Zhao S.-L. Liu D. Ding L.-Q. Liu G.-K. Yao T. Wu L.-L. Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways Int. Immunopharmacol 2024 142 Pt A 113069 10.1016/j.intimp.2024.113069
    [Google Scholar]
  95. Wang J. An G. Peng X. Zhong F. Zhao K. Qi L. Ma Y. Effects of three Huanglian-derived polysaccharides on the gut microbiome and fecal metabolome of high-fat diet/streptozocin-induced type 2 diabetes mice. Int. J. Biol. Macromol. 2024 273 Pt 1 133060 10.1016/j.ijbiomac.2024.133060 38871107
    [Google Scholar]
  96. Cao Z. Wang X. Liu H. Yang Z. Zeng Z. Gut microbiota mediate the alleviation effect of Xiehuo-Guzheng granules on β cell dedifferentiation in type 2 diabetes mellitus. Phytomedicine 2024 135 156151 10.1016/j.phymed.2024.156151 39437686
    [Google Scholar]
  97. Bai Y. Zhao Y. Jin J. Ye Z. Fan H. Zhao D. Gao S. Jiang Tang San Hao Formula exerts its anti-diabetic effect by affecting the gut-microbiota-brain axis. Phytomedicine 2024 135 156100 10.1016/j.phymed.2024.156100 39388919
    [Google Scholar]
  98. Ji H. Zhao X. Chen X. Fang H. Gao H. Wei G. Zhang M. Kuang H. Yang B. Cai X. Su Y. Piao C. Zhao S. Li L. Sun W. Xu T. Xu Q. Fan Y. Ye J. Yao C. Shang M. Song G. Chen L. Zheng Q. Xiao X. Yan L. Lian F. Tong X. Jia Z. Lun L. Hu S. Liu H. Cai G. Li H. Huang L. Tian M. Wan J. Song P. Zhang Y. Li F. Hu X. Xu J. Pang Y. Shi J. Cheng H. Tian W. Wang H. Qin G. Zhao Q. Wang L. Luo J. Liu L. Zhao L. Xie W. Cai X. Qiao G. Song A. Li J. Zhang W. Wu Q. Wang Y. Fang Q. Yue L. Zhang Y. Hu L. You Q. Wang L. Zhao S. Zhang L. Guo H. Dai L. Niu W. Gao W. Li M. Zhang R. Liu Y. Wang J. Zhang C. Li S. Feng Y. Dai Y. Sa R. Sang L. Wang H. Yin W. Zhang H. Sun F. Ma L. Yang J. Zhang X. Gan X. Sheng Y. Zhou Y. Lu J. Xu T. Li H. Li Z. Pan X. Zhang L. Han J. Yu A. Jing J. Huang L. Chen X. Wang X. Shi J. Wang B. Sun G. Li K. Zhou T. Shi M. Liu H. Sun X. Zhang H. Hong W. Huang N. Chen X. Zheng J. Juan Y. Zhou R. Wang H. Zang C. Lai Y. Peng Z. Chen R. Liu X. Cai M. Han X. Jinlida for diabetes prevention in impaired glucose tolerance and multiple metabolic abnormalities. JAMA Intern. Med. 2024 184 7 727 735 10.1001/jamainternmed.2024.1190 38829648
    [Google Scholar]
  99. Kang X. Jin D. Ji H. An X. Zhang Y. Duan L. Yang C. Zhou R. Duan Y. Zhang Y. Sun Y. Jiang L. Lian F. Tong X. The clinical efficacy of gegen qinlian decoction in treating type 2 diabetes is positively correlated with the dose of Coptidis rhizoma: Three randomized, doubleblind, dose-parallel controlled clinical trials. Drug Des. Devel. Ther. 2024 18 5573 5582 10.2147/DDDT.S487315 39650851
    [Google Scholar]
  100. Zhao X. An X. Cui Y. Dong L. Fang Z. Zheng Z. Zuo X. Gao H. Gao T. Ni Q. Lian F. Tong X. TangBi formula for painful diabetic distal symmetric polyneuropathy: A multicenter, randomized, double‐blind, placebo‐controlled and parallel‐group trial. J. Diabetes 2025 17 1 e70045 10.1111/1753‑0407.70045 39757352
    [Google Scholar]
  101. Chan K.W. Kwong A.S.K. Tan K.C.B. Lui S.L. Chan G.C.W. Ip T.P. Yiu W.H. Cowling B.J. Taam Wong V. Lao L. Feng Y. Lai K.N. Tang S.C.W. Add-on rehmannia-6–based Chinese medicine in type 2 diabetes and CKD. Clin. J. Am. Soc. Nephrol. 2023 18 9 1163 1174 10.2215/CJN.0000000000000199 37307005
    [Google Scholar]
  102. Pan J. Xu Y. Chen S. Tu Y. Mo Y. Gao F. Zhou J. Hu C. Jia W. The effectiveness of Traditional Chinese Medicine Jinlida granules on glycemic variability in newly diagnosed type 2 diabetes: A double-blinded, randomized trial. J. Diabetes Res. 2021 2021 1 8 10.1155/2021/6303063 34660811
    [Google Scholar]
  103. Huang H. Lin Y. Wei H. Fu Y. Zhou Y. Fang Z. Qiu X. Wang M. Li Q. Li S. Wang S. Dai F. Liu Z. Zhao L. Wen J. Wu L. Zeng H. Zhang J. Lu Q. He L. Song W. Sun L. Luo L. He J. Xie W. Liang Q. Huang Y. Zhu S. Long J. Gao Z. Wen Z. Li C. Ouyang W. Li G. Wu M. Li A. Huang J. Paul S.K. Tang X. Fan G. Effect and safety of herbal medicine foot baths in patients with diabetic peripheral neuropathy: A multicenter double-blind randomized controlled trial. Chin. J. Integr. Med. 2024 30 3 195 202 10.1007/s11655‑024‑3900‑8 38374490
    [Google Scholar]
  104. Liu J. Gao L. Fu B. Yang H. Zhang L. Che S. Xu Y. Du X. Liu Z. Xue Y. Lv C.X. Huang Y. Wang B.H. Gao S.X. Xing Y.F. Yuan X. Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial. Phytomedicine 2022 100 154079 10.1016/j.phymed.2022.154079 35413644
    [Google Scholar]
  105. Qu L. Liang X. Tian G. Zhang G. Wu Q. Huang X. Cui Y. Liu Y. Shen Z. Xiao C. Qin Y. Miao H. Zhang Y. Li Z. Ye S. Zhang X. Yang J. Cao G. Li Y. Yang G. Hu J. Wang X. Li Z. Li Y. Zhang X. Zhang G. Chen L. Hua W. Yu M. Lu C. Zhang X. Jiang H. Efficacy and safety of mulberry twig alkaloids tablet for the treatment of type 2 diabetes: A multicenter, randomized, double-blind, double-dummy, and parallel controlled clinical trial. Diabetes Care 2021 44 6 1324 1333 10.2337/dc20‑2109 33832957
    [Google Scholar]
  106. Yang H. Xia S. Cong Y. Yang X. Min J. Wu T. Effects of Qidan Tangshen Granule on diabetic kidney disease in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 2024 209 111128 10.1016/j.diabres.2024.111128 38311247
    [Google Scholar]
  107. Zhao J. Wang S. Li X. Zhang G. Xu Y. Zheng X. Guo J. Zhang Z. A prospective, multicentered, randomized, double-blind, placebo-controlled clinical trial of keluoxin capsules in the treatment of microalbuminuria in patients with type 2 early diabetic kidney disease. Journal of Integrative Complementary Medicine 2024 30 2 185 195 10.1089/jicm.2022.0809 37733303
    [Google Scholar]
  108. Huang T.H. Ke C.H. Chen C.C. Chuang C.H. Liao K.W. Shiao Y.H. Lin C.S. The Effects of freshwater clam (Corbicula fluminea) extract on serum tumor necrosis factor-alpha (TNF-α) in prediabetic patients in Taiwan. Mar. Drugs 2022 20 4 261 10.3390/md20040261 35447934
    [Google Scholar]
  109. Liao T. Zhao K. Huang Q. Tang S. Chen K. Xie C. Zhang C. Gan W. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease. Medicine 2020 99 31 e21137 10.1097/MD.0000000000021137 32756091
    [Google Scholar]
  110. Lu Q. Chen B. Liang Q. Wu L. Luo L. Li A. Ouyang W. Wen Z. Liu Y. Lu J. Liu Y. Fan G. Liu Z. Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single-center, randomized, single-blind, double-dummy, and parallel controlled clinical trial. J. Diabetes 2022 14 8 551 561 10.1111/1753‑0407.13306 36040201
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010445359251204044548
Loading
Application of Traditional Chinese Medicines in Diabetes Mellitus: From Pathogenesis to Clinical Practice
Bentham Science Publishers ; https://doi.org/10.2174/0113892010445359251204044548
/content/journals/cpb/10.2174/0113892010445359251204044548
/content/journals/cpb/10.2174/0113892010445359251204044548
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: diabetes mellitus ; preclinical application ; pathogenesis and risk factors ; Traditional chinese medicine ; mechanisms ; clinical application

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test